AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

IGC Pharma, Inc. Director's Dealing 2021

Jun 4, 2021

34705_dirs_2021-06-04_939a19d5-292e-4fa8-9e35-6af6c9b8d1d1.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2021-05-13

Reporting Person: LYNCH John Edward (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
COMMON STOCK	96901	Direct
COMMON STOCK	150000	Direct

Footnotes

F1: Represents restricted shares of common stock subject to vesting over three years.